COVID-19 has tragically elevated mortality for Canadians and increased the uncertainty of future longevity prospects, but it also has created the potential for future longevity gains. The author explores ways for plan sponsors and trustees to better understand longevity risk and discuss with their actuaries appropriate estimates of future longevity for their plan members.
